Bolt Biotherapeutics COO Grant Yonehiro Sells $38.5K of Stock
Grant Yonehiro, COO, sold 11,759 shares of Bolt Biotherapeutics, Inc. at $3.24 to $3.32 a share (average $3.27) in 2 transactions, worth $38.5K in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 17,269 (-28.4%).
Bolt Biotherapeutics Senior VP, Finance and PAO Sarah Nemec Sells $13.2K of Stock
Sarah Nemec, Senior VP, Finance and PAO, sold 4,077 shares of Bolt Biotherapeutics, Inc. at $3.24 a share, worth $13.2K in total on Sep 18, 2026. Shares held after the trade: 17,082 (-19.3%).
Bolt Biotherapeutics President, CEO and CFO William P. Quinn Sells $51.3K of Stock
William P. Quinn, President, CEO and CFO, sold 15,677 shares of Bolt Biotherapeutics, Inc. at $3.24 to $3.32 a share (average $3.27) in 2 transactions, worth $51.3K in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 25,384 (-26.5%).